Uwell Biopharma Company Description

Uwell Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel cancer immunotherapeutic in Taiwan.

The company provides chimeric antigen receptor T-cell (CAR-T) therapy platforms, lentiviral vector production, and related services.

The company was founded in 2020 and is based in New Taipei City, Taiwan.

Uwell Biopharma, Inc.

Country	Taiwan
Founded	2020
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: Xintai 5 Road New Taipei City, 221416 Taiwan
Phone	886 2 2697 2200
Website	uwell.com.tw

Stock Details

Ticker Symbol	7902
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
SIC Code	2836